Company intelligence / Profile preview

Anebulo Pharmaceuticals

Lakeway/Austin area, Texas, United Statesanebulo.com ↗

Ownership: Public · ANEB
Development stage: Phase 2

Overview

Anebulo’s lead candidate selonabant (formerly ANEB-001) has completed a randomized, double-blind, placebo-controlled Phase 2 clinical trial demonstrating favorable tolerability and efficacy in rapidly reversing the effects of THC-induced acute cannabinoid intoxication. The company observed rapid reversal of key symptoms even with delayed dosing and plans to advance an intravenous formulation for pediatric use into clinical trials in 2025. Discussions with the FDA are ongoing regarding registrational trial design

Therapeutic areas: Psychiatry
Modalities: small molecules (competitive CB1 receptor antagonists)
Industry: Biotech

Drug pipeline

1 asset

ANEB-001

Phase 2

Indications: Cannabinoid intoxication

Partnerships

No major pharmaceutical or biotech partnerships disclosed as of May 2025; recent financing from investment funds including directors’ affiliates

Financials

Market cap: $13.5M
Total revenue: $0
Enterprise value: $4.5M

Beyond the preview

Go deeper on Anebulo Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anebulo Pharmaceuticals.

Explore the full profile